Nov 26, 2019Alpha Tau Announces the Publication of Exceptional Clinical Data from Alpha DaRT, its Novel Alpha RaAlpha DaRT™ achieves a 78.6% complete response rate in management of challenging squamous cell carcinoma tumors. Tel Aviv, Israel,...
Nov 7, 2018Alpha Tau Medical Launches New Clinical Trials in Italy with Leading Cancer Centers, La Sapienza andTrials will investigate the efficacy of its breakthrough cancer treatment, Alpha DaRT, in Squamous Cell Carcinoma (SCC) of the Skin, and...